244
Views
5
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Effect of Nicotine on RANKL and OPG and Bone Mineral Density

, MD, , MD, , MD, , MD, , MD & , MD
Pages 327-331 | Received 01 Dec 2013, Accepted 15 Apr 2014, Published online: 15 May 2014

REFERENCES

  • Atkins GJ, Welldon KJ, Holding CA, The induction of a catabolic phenotype in human primary osteoblasts and osteocytes by polyethylene particles. Biomaterials 2009;30:3672–3681.
  • Probst A, Spiegel HU. Cellular mechanisms of bone repair. J Invest Surg. 1997;10:77–86.
  • Barbieri RL, Gochberg J, Ryan KJ. Nicotine, cotinine, and anabasine inhibit aromatase in human trophoblast in vitro. J Clin Invest. 1986;77:1727–1733.
  • Burguet A, Kaminski M, Abraham-Lerat L. The complex relationship between smoking in pregnancy and very preterm delivery: results of the Epipage study. BJOG. 2004;111:258–265.
  • Demir B, Haberal A, Geyik P, Identification of the risk factors for osteoporosis among postmenopausal women. Maturitas 2008;60:253–256.
  • Eghbali-Fatourechi G, Khosla S, Sanyal A, Role of RANK ligand in mediating increased bone resorption in early postmenopausal women. J Clin Invest. 2003;111:1221–1230.
  • LaCroix AZ, Jackson RD, Aragaki A, OPG and sRANKL serum levels and incident hip fracture in postmenopausal Caucasian women in the Women's Health Initiative Observational Study. Bone 2013;56:474–481.
  • Wang XF, Zhang YK, Yu ZS, The role of the serum RANKL/OPG ratio in the healing of intertrochanteric fractures in elderly patients. Mol Med Rep. 2013;7:1169–1172.
  • Walker LM, Preston MR, Magnay JL, Nicotinic regulation of c-fos and osteopontin expression in human-derived osteoblast like cells and human trabecular bone organ culture. Bone 2001;28:603–608.
  • Rothem DE, Rothem L, Soudry M, Nicotine modulates bone metabolism-associated gene expression in osteoblast cells. J Bone Miner Metab. 2009;27:555–561.
  • Hapidin H, Othman F, Soelaiman IN, Negative effects of nicotine on bone-resorbing cytokines and bone histomorphometric parameters in male rats. J Bone Miner Metab. 2007;25:93–98.
  • Syversen U, Nordsletten L, Falch JA, Effect of lifelong nicotine inhalation on bone mass and mechanical properties in female rat femurs. Calcif Tissue Int. 1999;65:246–249.
  • Iwaniec UT, Haynatzki GR, Fung YK, Effects of nicotine on bone and calciotropic hormones in aged ovariectomized rats. J Musculoskelet Neuronal Interact. 2002;2:469–478.
  • Porter SE, Hanley EN. The musculoskeletal effects of smoking. J Am Acad Orthop Surg. 2001;9:9–17.
  • Rudäng R, Darelid A, Nilsson M, Smoking is associated with impaired bone mass development in young adult men: a 5-year longitudinal study. J Bone Miner Res. 2012;27:2189–2197.
  • Hoidrup S, Prescott E, Sørensen TI, Tobacco smoking and risk of hip fracture in men and women. Int J Epidemiol. 2000;29:253–259.
  • Lambers DS, Clark KE. The maternal and fetal physiologic effects of nicotine. Semin Perinatol. 1996;20:115–126.
  • Hapidin H, Othman F, Soelaiman IN, Effects of nicotine administration and nicotine cessation on bone histomorphometry and bone biomarkers in Sprague-Dawley male rats. Calcif Tissue Int. 2011;88:41–47.
  • Gullihorn L, Karpman R, Lippiello L. Differential effects of nicotine and smoke condensate on bone cell metabolic activity. J Orthop Trauma. 2005;19:17–22.
  • Rogers A, Saleh G, Hannon RA, Circulating estradiol and osteoprotegerin as determinants of bone turnover and bone density in postmenopausal women. J Clin Endocrinol Metab. 2002;87:4470–4475.
  • Indridason OS, Franzson L, Sigurdsson G. Serum osteoprotegerin and its relationship with bone mineral density and markers of bone turnover. Osteoporos Int. 2005;16:417–423.
  • Jorgensen L, Vik A, Emaus N, Bone loss in relation to serum levels of osteoprotegerin and nuclear factor-kappaB ligand: the Tromso study. Osteoporos Int. 2010;21:931–938.
  • Oh KW, Rhee EJ, Lee WY, Circulating osteoprotegerin and receptor activator of NF-kappaB ligand system are associated with bone metabolism in middle-aged males. Clin Endocrinol (Oxf). 2005;62:92–98.
  • Chiba Y, Onouchi T, Ikeda T, Implications of measuring soluble receptor activators of nuclear factor kappa B ligand and osteoprotegerin in bone metabolism of elderly women. Gerontology 2009;55:275–280.
  • Mezquita-Raya P, de la Higuera M, Garcia DF, The contribution of serum osteoprotegerin to bone mass and vertebral fractures in postmenopausal women. Osteoporos Int. 2005;16:1368–1374.
  • Liu JM, Zhao HY, Ning G, Relationships between the changes of serum levels of OPG and RANKL with age, menopause, bone biochemical markers and bone mineral density in Chinese women aged 20–75. Calcif Tissue Int. 2005;76:1–6.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.